Literature DB >> 16923994

Adult hypertension in intrauterine growth-restricted offspring of hyperinsulinemic rats: evidence of subtle renal damage.

Michael Bursztyn1, Marie-Luise Gross, Tania Goltser-Dubner, Nadja Koleganova, Tatiana Birman, Yoav Smith, Ilana Ariel.   

Abstract

In humans, intrauterine growth-restricted newborns are prone to develop hypertension as adults. We studied a rat model of pregnancy-induced hypertension associated with intrauterine growth restriction (IUGR) produced by chronic administration of insulin. Fetuses of hyperinsulinemic dams (HDs) were smaller than those of normal dams (5.1+/-0.4 g versus 5.6+/-0.1 g, respectively; P<0.05). At 16 weeks of age, tail-cuff systolic blood pressure was measured, the rats were placed in metabolic cages and euthanized, and the kidneys were examined. Male but not female offspring of HDs (n=9) had higher blood pressure than normal-pregnancy offspring (n=12; 148+/-11 mm Hg versus 118+/-14 mm Hg; P<0.004). In contrast to other models, there was no difference in ours in the number and volume of glomeruli. However, there were significantly greater glomerular, tubulointerstitial, and vascular damage indices in the kidneys of male HD offspring versus controls (2.01+/-0.34 versus 1.08+/-0.16, 1.80+/-0.34 versus 0.76+/-0.12, and 2.13+/-0.81 versus 0.78+/-0.16, respectively; P<0.0001), with similar tubulointerstitial findings in females. Increased expression of collagen type IV, a kidney damage marker indicating fibrosis, was found in the tubulointerstitium. This may be associated with downregulation of bone morphogenetic protein 6, a presumptive antifibrogenic agent, at the end of gestation. In conclusion, male offspring of HDs displayed IUGR and adult hypertension accompanied by several indices of renal fibrosing damage, mainly in the renal tubulointerstitium. Our findings suggest that there is >1 pathway of fetal programming leading from IUGR to development of hypertension in later life.

Entities:  

Mesh:

Year:  2006        PMID: 16923994     DOI: 10.1161/01.HYP.0000237973.64711.e2

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Prenatal programming-effects on blood pressure and renal function.

Authors:  Eberhard Ritz; Kerstin Amann; Nadezda Koleganova; Kerstin Benz
Journal:  Nat Rev Nephrol       Date:  2011-02-01       Impact factor: 28.314

2.  Role of fetal programming in the development of hypertension.

Authors:  Norma B Ojeda; Daniela Grigore; Barbara T Alexander
Journal:  Future Cardiol       Date:  2008-03

Review 3.  Oxygenomics in environmental stress.

Authors:  H Sone; H Akanuma; T Fukuda
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

4.  Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis.

Authors:  Amélie Dendooven; Olivia van Oostrom; Dionne M van der Giezen; Jan Willem Leeuwis; Cristel Snijckers; Jaap A Joles; Elizabeth J Robertson; Marianne C Verhaar; Tri Q Nguyen; Roel Goldschmeding
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 5.  Fetal programming and early identification of newborns at high risk of free radical-mediated diseases.

Authors:  Serafina Perrone; Antonino Santacroce; Anna Picardi; Giuseppe Buonocore
Journal:  World J Clin Pediatr       Date:  2016-05-08

6.  Maternal insulin resistance and transient hyperglycemia impact the metabolic and endocrine phenotypes of offspring.

Authors:  Sevim Kahraman; Ercument Dirice; Dario F De Jesus; Jiang Hu; Rohit N Kulkarni
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-23       Impact factor: 4.310

7.  BMP6 reverses TGF-beta1-induced changes in HK-2 cells: implications for the treatment of renal fibrosis.

Authors:  Ji-Dong Yan; Shuang Yang; Jie Zhang; Tian-Hui Zhu
Journal:  Acta Pharmacol Sin       Date:  2009-06-22       Impact factor: 6.150

8.  Birth Weight and Maternal Body Size as Determinants of Blood Pressure at Age 17: Results from the Jerusalem Perinatal Study Cohort.

Authors:  Uri P Dior; Gilad Karavani; Michael Bursztyn; Ora Paltiel; Ronit Calderon-Margalit; Yechiel Friedlander; Iaroslav Youssim; Orly Manor; Hagit Hochner
Journal:  Matern Child Health J       Date:  2020-11-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.